OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment
Ijeoma Theresa Achi, Paromita Sarbadhikary, Blassan P. George, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3433-3433
Open Access | Times Cited: 25

Showing 25 citing articles:

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases
Qian Lu, Yanli Zhu, Chao Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 47

Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Gabriele De Rubis, Keshav Raj Paudel, Leander Corrie, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2793-2833
Closed Access | Times Cited: 27

Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer
Aditi Sharma, Lalit Sharma, Shouvik Kumar Nandy, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 750-750
Open Access | Times Cited: 18

Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
Qi Wang, Hua Wu, Qingquan Wu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 907-921
Closed Access | Times Cited: 13

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs
Hongrui Zhou, Mengxue Zhang, Hui‐Hui Cao, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1734-1734
Open Access | Times Cited: 12

Phytochemistry and pharmacology of alkaloids from Papaver spp.: a structure–activity based study
Shekoufeh Aalinezhad, Farid Dabaghian, Aida Namdari, et al.
Phytochemistry Reviews (2024)
Closed Access | Times Cited: 2

A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
Anetta Sulewska, Lothar R. Pilz, Christian Manegold, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 905-905
Open Access | Times Cited: 7

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action
Lu Zhan, Fangting Su, Qiang Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7

Berberine Synergizes with Cisplatin via Inducing Apoptosis on A549 non-Small Cell Lung Cancer Cells
Merve Becit-Kızılkaya, Şeyma Öncü, Serkan Şen, et al.
European Journal of Therapeutics (2023) Vol. 29, Iss. 3, pp. 480-488
Open Access | Times Cited: 5

Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer
Rong Wu, Zhichao Xi, Mengfan Liu, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4

Simulated weightlessness induces hippocampal insulin resistance and cognitive impairment
Jiahui Li, Caiyan Xue, Hongyan Yang, et al.
Life Sciences (2023) Vol. 333, pp. 122112-122112
Closed Access | Times Cited: 4

Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis
Tingting Lu, Yu Wang, Fang Liu, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7797-7797
Open Access | Times Cited: 4

Advances in Plants-Derived Bioactives for Cancer Treatment
Natália Martins
Cells (2023) Vol. 12, Iss. 8, pp. 1112-1112
Open Access | Times Cited: 3

An Insight into Emerging Phytocompounds for Glioblastoma Multiforme Therapy
Vijeta Prakash, Reema Gabrani
Cardiovascular & Hematological Agents in Medicinal Chemistry (2023) Vol. 22, Iss. 3, pp. 336-347
Closed Access | Times Cited: 2

Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications
Xiaodan Xu, He Yuanyuan, Jungang Liu
Gene (2024), pp. 149021-149021
Closed Access

Berberrubine, an Attractive derivative of berberine with multiple pharmacological activities
Yi Li, Gangmin Li, Cheng Peng, et al.
Arabian Journal of Chemistry (2024) Vol. 18, Iss. 1, pp. 106045-106045
Open Access

Divulging the potency of naturally derived photosensitizers in green PDT: an inclusive review Of mechanisms, advantages, and future prospects
Muskan Gupta, Anwesha Sahu, Tuhin Mukherjee, et al.
Photochemical & Photobiological Sciences (2024)
Closed Access

MDM2 up-regulates the energy metabolism in NSCLC in a p53-independent manner
Elizaveta Fefilova, Yulia Kirdeeva, Sergey Parfenyev, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 743, pp. 151169-151169
Closed Access

Anticancer Potential of Nature-Derived Isoquinoline Alkaloids (A Review)
Liu Bi, Ken Liu, Jun Wang, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 5, pp. 1294-1310
Closed Access | Times Cited: 1

Mitochondrial targeting derivatives of honokiol enhanced selective antitumor activity in NCI-H446 cells and decreased in vivo toxicity in Caenorhabditis elegans
Huicong Miao, Wenbo Cui, Tao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115996-115996
Closed Access | Times Cited: 1

Simultaneous effect of progesterone and berberine on the level of reactive oxygen species in K562 cell
Mohammad Zangooei, Vahid Bagheri
Sālnāmah va āmār. (2023) Vol. 30, Iss. 1, pp. 99-106
Closed Access | Times Cited: 1

Page 1

Scroll to top